Padmanabh P. Bhatt Supernus Pharmaceuticals, Inc. (SUPN) insider trading activity

Padmanabh P. Bhatt is Sr. VP of IP, CSO of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 9,679 shares of SUPN, which is worth approximately $310,986. The most recent transaction as insider was on Aug 20, 2024, when has been sold 572 shares (Common Stock) at a price of $29.57 per share, resulting in proceeds of $16,914. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.68K

12.94% 3M change

35.09% 12M change

Total Value Held $310,986

Padmanabh P. Bhatt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 20 2024	SELL Payment of exercise price or tax liability	$16,914 $29.57 p/Share	572 Reduced 5.58%	9,679 Common Stock
Aug 20 2024	BUY Exercise of conversion of derivative security	-	1,250 Added 10.87%	10,251 Common Stock
Mar 21 2024	SELL Open market or private sale	$511,677 $35.31 p/Share	14,491 Reduced 62.84%	8,570 Common Stock
Mar 21 2024	BUY Exercise of conversion of derivative security	$366,622 $25.3 p/Share	14,491 Added 38.59%	23,061 Common Stock
Mar 20 2024	SELL Open market or private sale	$14,124 $35.31 p/Share	400 Reduced 4.46%	8,570 Common Stock
Mar 20 2024	BUY Exercise of conversion of derivative security	$10,120 $25.3 p/Share	400 Added 4.27%	8,970 Common Stock
Mar 19 2024	SELL Open market or private sale	$436,572 $35.31 p/Share	12,364 Reduced 59.06%	8,570 Common Stock
Mar 19 2024	BUY Exercise of conversion of derivative security	$312,809 $25.3 p/Share	12,364 Added 37.13%	20,934 Common Stock
Mar 13 2024	SELL Open market or private sale	$2,107,347 $33.79 p/Share	62,366 Reduced 87.92%	8,570 Common Stock
Mar 13 2024	BUY Exercise of conversion of derivative security	$1,153,147 $18.49 p/Share	62,366 Added 58.26%	44,686 Common Stock
Mar 12 2024	SELL Open market or private sale	$128,133 $32.99 p/Share	3,884 Reduced 31.19%	8,570 Common Stock
Mar 12 2024	BUY Exercise of conversion of derivative security	$50,414 $12.98 p/Share	3,884 Added 23.77%	12,454 Common Stock
Feb 26 2024	SELL Open market or private sale	$151,050 $30.21 p/Share	5,000 Reduced 36.85%	8,570 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	$45,650 $9.13 p/Share	5,000 Added 26.93%	13,570 Common Stock
Feb 23 2024	SELL Payment of exercise price or tax liability	$18,540 $29.06 p/Share	638 Reduced 6.93%	8,570 Common Stock
Feb 23 2024	BUY Grant, award, or other acquisition	-	1,250 Added 11.95%	9,208 Common Stock
Feb 22 2024	SELL Payment of exercise price or tax liability	$10,393 $27.94 p/Share	372 Reduced 4.47%	7,958 Common Stock
Feb 22 2024	BUY Grant, award, or other acquisition	-	750 Added 8.26%	8,330 Common Stock
Sep 07 2023	SELL Payment of exercise price or tax liability	$37,942 $32.1 p/Share	1,182 Reduced 14.16%	7,165 Common Stock
Sep 07 2023	BUY Exercise of conversion of derivative security	-	2,500 Added 23.05%	8,347 Common Stock
May 11 2023	BUY Exercise of conversion of derivative security	-	750 Added 12.01%	5,497 Common Stock
Apr 11 2023	BUY Grant, award, or other acquisition	-	1,500 Added 24.01%	4,747 Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	750 Added 18.76%	3,247 Common Stock
Jan 17 2023	SELL Open market or private sale	$192,653 $39.92 p/Share	4,826 Reduced 74.59%	1,644 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	$44,061 $9.13 p/Share	4,826 Added 42.72%	6,470 Common Stock

PPB

Padmanabh P. Bhatt

Sr. VP of IP, CSO

Rockville, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SUPN shares.

Notify only if

Value

Insider Trading

Get notified when an Supernus Pharmaceuticals, Inc. insider buys or sells SUPN shares.

Notify only if

Operation

Value

Type

News

Receive news related to SUPERNUS PHARMACEUTICALS, INC.

Track Activities on SUPN

Account